Global Single-use Bioreactors Market: Overview
The use of single-use bioreactors across the global pharmaceutical industry has significantly increased since inception roughly two decades back. The market for these disposable bioreactors continues to tread along a healthy growth path as pharmaceutical companies begin to understand the immense flexibility and several other advantages associated with their use. For multi-drug producing pharmaceutical units, especially, single-use bioreactors mitigate the risk of cross-contamination and save significant time that is otherwise spent for cleaning and clearance validation to assure that no compounds are carried over from prior batches.
By lowering down the costs involved in cleaning and sterilizing bioreactors and increasing the operational flexibility of the entire drug manufacturing process, the use of single-use bioreactors leads to reduced capital expenditure costs. Owing to these factors, the preference for single-use bioreactors has significantly increased over the conventional stainless steel reactors in the past years.
An increasingly rising number of pharmaceutical companies are presently preferring the use of disposables for applications such as filtration, media preparation, purification, cell harvesting, virus inactivation, and buffer preparation. In the next few years, single-use bioreactors will play a central role in the pharmaceutical industry, supporting the need for the rapid development of novel drug varieties to tackle the vast array of diseases that are presently untreated or are becoming increasingly prevalent.
Global Single-use Bioreactors Market: Scope of the Report
This report on the global market for single-use bioreactors presents a thorough overview of the market’s present state and a forecast regarding the future growth prospects of the market and its key segments over the period between 2016 and 2024. The report presents a thorough analysis of the key factors, such as drivers, challenges, past and present trends, competition, and regulatory landscape of the market, which are expected to have a notable influence on the future growth prospects of the market over the said period.
The report includes rich qualitative and quantitative data pertaining to these factors, gathered with the help of several primary as well as secondary research methodologies over the past few years. The report also includes an analysis of various market elements with the help of research methodologies such as Porter’s five forces analysis, which helps gauge the intensity of the key forces defining the competitive intensity and thus the attractiveness of a market for potential entrants.
The report also presents a detailed overview of the key micro and macroeconomic factors expected to have a wide-ranging impact on the market’s development over the period between 2016 and 2024. The report, with all this data, makes for a data repository that can aid companies in the market to formulate optimal growth strategies for promising returns in the field of single-use bioreactors.
Global Single-use Bioreactors Market: Drivers and Restraints
The significantly rising cost pressures in the pharmaceutical industry and the increasing demand for new drug varieties to serve a vast number of new and untreated disease categories are compelling companies to reevaluating their operational and manufacturing processes. The use of single-use bioreactors is chiefly driven due to these pressures and an increasing number of pharmaceutical companies are adopting disposable bioreactors to speed-up the introduction of new product lines.
The market is witnessing significant developments in terms of materials, variety, and flexibility of bioreactors to be used across a large set of culture mediums. Several varieties of single-use technologies such as mixers, disposable vessels, and bioreactor bags have started to proliferate the market and an increasing number of manufacturers are venturing into to field to exploit the vast growth opportunities.
Global Single-use Bioreactors Market: Geographical and Competitive Dynamics
In terms of geography, the market for single-use bioreactors is presently dominated by North America and Europe owing to the presence of a large number of some of the world’s leading biopharmaceutical companies. In the near future, the market is also expected to witness promising growth opportunities in regions such as Asia-Pacific and Latin America as many international biopharmaceutical companies operate in these regions through large-scale manufacturing facilities in these regions.
The global market for single-use bioreactors market has become highly dynamic in the past few years, chiefly owing to new entrants and vast positive developments in the area of product variants. Some of the key vendors presently operating in the market are Sartorius Stedim Biotech, GE Healthcare, PBS Biotech, Thermo Fisher Hyclone, Merck Millipore, Xcellerex, and Cellexus Limited.
Note : All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Transparency Market Research.